Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes

Rhea-AI Filing Summary

TREACE MEDICAL CONCEPTS, INC. reported that Chief Financial Officer Mark Hair had 37,102 shares of common stock withheld or delivered on August 9, 2026 to satisfy exercise price or tax liability. Following this code F disposition, he directly holds 914,900 shares of common stock, including 717,604 restricted stock units.

Insider Trade Summary

Net Seller: 37,102 shares

Net Sell 1 txn

Insider Hair Mark

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock F1	37,102	$0.00	$0.00

Holdings After Transaction: Common Stock — 914,900 shares (Direct)

Footnotes (1)

1. F1. Includes 717,604 restricted stock units.

Key Figures

Shares delivered/withheld: 37,102 shares Shares held after transaction: 914,900 shares Restricted stock units included: 717,604 units

3 metrics

Shares delivered/withheld 37,102 shares Code F disposition on August 9, 2026 to cover exercise price or tax liability

Shares held after transaction 914,900 shares Direct TMCI common stock holdings of CFO after reported transaction

Restricted stock units included 717,604 units Restricted stock units included within the reported 914,900-share holding

Key Terms

restricted stock units, transaction code F, exercise price or tax liability

3 terms

restricted stock units financial

"Includes 717,604 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

transaction code F financial

"transaction_code_description: Payment of exercise price or tax liability"

exercise price or tax liability financial

"Payment of exercise price or tax liability by delivering or withholding securities"

FAQ

What insider transaction did TMCI CFO Mark Hair report?

Mark Hair reported a Form 4 transaction where 37,102 TMCI common shares were delivered or withheld on August 9, 2026 to cover exercise price or tax liability, classified under transaction code F.

Did the TMCI CFO sell shares in the open market in this Form 4?

The reported Form 4 shows a code F transaction, meaning 37,102 shares were delivered or withheld for exercise price or tax liability, not a standard open-market purchase or sale transaction.

How many TMCI shares does the CFO hold after this transaction?

After the August 9, 2026 transaction, the TMCI Chief Financial Officer directly holds 914,900 shares of common stock, which the filing notes includes 717,604 restricted stock units.

What does transaction code F mean in the TMCI Form 4 filing?

In this TMCI Form 4, transaction code F indicates payment of exercise price or tax liability by delivering or withholding securities, here covering 37,102 shares of common stock on August 9, 2026.

How many restricted stock units does the TMCI CFO have?

A footnote to the Form 4 states that Mark Hair’s reported holdings include 717,604 restricted stock units, which are part of his total 914,900 TMCI common shares position after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 05:30 PM Accepted by SEC EDGAR 08/12/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hair Mark

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/09/2026		F		37,102	D	$0	914,900(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 717,604 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Mark Hair	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)